Publication | Closed Access

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

Promising Somatostatin AnalogueEngineeringIndium-111 LabellingNovel TherapyMedicineRadionuclide TherapyTheranosticsRadiopharmaceutical TherapyPharmacotherapyPharmacologyRadiation OncologyNuclear MedicineDrug Discovery